- CGEN -3.79%
Compugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance · 6 days ago
Open | 2.0700 |
High | 2.0850 |
Low | 2.0000 |
Mkt Cap | 181.75M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 2.1100 |
52 Wk. Low | 0.5300 |
52 Wk. High | 3.0300 |
Related stocks
Publicly traded Israeli drug discovery company
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.56M | - |
Net Income | -7.27M | - |
Diluted EPS | -0.08 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.07 | - |
Q1 2024 | -$0.02 | -$0.08 |
Q4 2023 | $0.22 | $0.11 |
S&P FuturesES=F | 5,365.75-5.50 (-0.10%) |
Dow FuturesYM=F | 38,870.00-59.00 (-0.15%) |
Nasdaq FuturesNQ=F | 19,084.75-25.00 (-0.13%) |
Apple Inc.AAPL | 193.12-1.91% |
865.00+1.77% | |
160.34-4.49% |